Better than nothing : Last week the U.S. Food and Drug Administration gave the go-ahead to test a less-than-perfect AIDS vaccine-the first approved for wide-scale human trials. The new vaccine, AIDVAX, developed by VaxGen, contains snippets of two strains of HIV yet has proved safe.